Acute orbitocranial inflammation following radioimmunotherapy for non-Hodgkin lymphoma.
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan may result in hemorrhagic tumor necrosis with acute orbital and intracranial inflammation.
Hwang
John C
JC
Edward S. Harkness Eye Institute, Columbia University Medical Center, New York, New York 10032, USA.
El-Sawy
Tarek
T
Zoumalan
Christopher I
CI
Zain
Jasmine
J
O'Connor
Owen A
OA
Kazim
Michael
M
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018951:Antigens, CD20; D004660:Encephalitis / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000532:radiotherapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D054517:Orbital Cellulitis / Q000175:diagnosis / Q000209:etiology*; D009918:Orbital Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000009:adverse effects*; D015021:Yttrium Radioisotopes
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan